Keywords: watson, pharma, bid, 9b, andrx, pharmaceuticals, says

Watson Pharma bid $1.9B for Andrx

Article | 20 March 2006

Print This

Watson Pharmaceuticals says it has reached a definitive merger agreement to acquire all outstanding shares of common stock of fellow ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in